<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>TB R&#38;D Matters Blog &#187; Video</title>
	<atom:link href="http://www.newtbdrugs.org/blog/category/video/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.newtbdrugs.org/blog</link>
	<description>Working Towards a Faster Cure for Tuberculosis</description>
	<lastBuildDate>Sat, 19 May 2012 12:57:01 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
		<item>
		<title>Announcing the InnovateTB Contest</title>
		<link>http://www.newtbdrugs.org/blog/announcing-the-innovatetb-contest/</link>
		<comments>http://www.newtbdrugs.org/blog/announcing-the-innovatetb-contest/#comments</comments>
		<pubDate>Sat, 24 Mar 2012 04:01:13 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Announcements]]></category>
		<category><![CDATA[Events]]></category>
		<category><![CDATA[Video]]></category>
		<category><![CDATA[Voices from the Fight to Stop Tuberculosis]]></category>
		<category><![CDATA[InnovateTB]]></category>
		<category><![CDATA[InTB]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=3623</guid>
		<description><![CDATA[Announcing the InnovateTB contest! Innovations are revolutionizing TB. Tell us your story! On World TB Day, the Stop TB Partnership Working Group on New TB Drugs (WGND) announces the InnovateTB Contest to encourage and highlight innovations to achieve zero deaths from TB in this generation. We are inviting interested participants to take two simple steps: [...]]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/announcing-the-innovatetb-contest/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Kick TB Campaign:  Scoring Big in South Africa and Beyond</title>
		<link>http://www.newtbdrugs.org/blog/kick-tb-campaign-scoring-big-in-south-africa-and-beyond/</link>
		<comments>http://www.newtbdrugs.org/blog/kick-tb-campaign-scoring-big-in-south-africa-and-beyond/#comments</comments>
		<pubDate>Wed, 18 Jan 2012 19:22:32 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Faces of TB]]></category>
		<category><![CDATA[TB Prevention and Control Strategies]]></category>
		<category><![CDATA[Video]]></category>
		<category><![CDATA[Voices from the Fight to Stop Tuberculosis]]></category>
		<category><![CDATA[advocacy]]></category>
		<category><![CDATA[children]]></category>
		<category><![CDATA[community]]></category>
		<category><![CDATA[innovations]]></category>
		<category><![CDATA[South Africa]]></category>
		<category><![CDATA[voices]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=3403</guid>
		<description><![CDATA[The Kick TB Campaign is a unique project that uses the World's most popular sport to educate and engage young people in the effort to stop the spread of tuberculosis (TB).  ]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/kick-tb-campaign-scoring-big-in-south-africa-and-beyond/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Interview with TB Alert&#8217;s Mike Mandelbaum</title>
		<link>http://www.newtbdrugs.org/blog/interview-with-tb-alerts-mike-mandelbaum/</link>
		<comments>http://www.newtbdrugs.org/blog/interview-with-tb-alerts-mike-mandelbaum/#comments</comments>
		<pubDate>Thu, 21 Jul 2011 16:03:09 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Video]]></category>
		<category><![CDATA[Voices from the Fight to Stop Tuberculosis]]></category>
		<category><![CDATA[advocacy]]></category>
		<category><![CDATA[voices]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=2977</guid>
		<description><![CDATA[Mike Mandelbaum is Chief Executive of TB Alert, which is the UK's National and International Tuberculosis charity - the only British charity working solely on fighting TB in the UK and overseas.]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/interview-with-tb-alerts-mike-mandelbaum/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Video: Jenniffer Dietrich, Challenge Facility for Civil Society</title>
		<link>http://www.newtbdrugs.org/blog/video-jenniffer-dietrich-challenge-facility-for-civil-society/</link>
		<comments>http://www.newtbdrugs.org/blog/video-jenniffer-dietrich-challenge-facility-for-civil-society/#comments</comments>
		<pubDate>Fri, 01 Jul 2011 13:22:20 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[TB Patient Perspective]]></category>
		<category><![CDATA[TB Prevention and Control Strategies]]></category>
		<category><![CDATA[Video]]></category>
		<category><![CDATA[Voices from the Fight to Stop Tuberculosis]]></category>
		<category><![CDATA[community]]></category>
		<category><![CDATA[innovations]]></category>
		<category><![CDATA[stop tb]]></category>
		<category><![CDATA[voices]]></category>
		<category><![CDATA[WHO]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=2912</guid>
		<description><![CDATA[Jenniffer Dietrich is Technical Officer at the Challenge Facility for Civil Society of the Stop TB Partnership. ]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/video-jenniffer-dietrich-challenge-facility-for-civil-society/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Video: Global Fund in the Dominican Republic</title>
		<link>http://www.newtbdrugs.org/blog/video-global-fund-in-the-dominican-republic/</link>
		<comments>http://www.newtbdrugs.org/blog/video-global-fund-in-the-dominican-republic/#comments</comments>
		<pubDate>Thu, 23 Jun 2011 12:00:23 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[TB Patient Perspective]]></category>
		<category><![CDATA[TB Prevention and Control Strategies]]></category>
		<category><![CDATA[Video]]></category>
		<category><![CDATA[dominican republic]]></category>
		<category><![CDATA[global fund]]></category>
		<category><![CDATA[voices]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=2858</guid>
		<description><![CDATA[This video documents what the Global Fund has done and can do more of to save lives and prevent infections by engaging affected communities.]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/video-global-fund-in-the-dominican-republic/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Video: Global Fund Impact in Indonesia</title>
		<link>http://www.newtbdrugs.org/blog/video-global-fund-impact-in-indonesia/</link>
		<comments>http://www.newtbdrugs.org/blog/video-global-fund-impact-in-indonesia/#comments</comments>
		<pubDate>Sat, 18 Jun 2011 19:13:27 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[TB Prevention and Control Strategies]]></category>
		<category><![CDATA[Video]]></category>
		<category><![CDATA[Voices from the Fight to Stop Tuberculosis]]></category>
		<category><![CDATA[global fund]]></category>
		<category><![CDATA[indonesia]]></category>
		<category><![CDATA[treatment]]></category>
		<category><![CDATA[voices]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=2836</guid>
		<description><![CDATA[This video presents interviews with a diverse range of stakeholders on the positive impact that Global Fund financing has had for Indonesia's national programme. This post also includes another perspective from Kenya.]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/video-global-fund-impact-in-indonesia/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Call to Action on Childhood TB</title>
		<link>http://www.newtbdrugs.org/blog/call-to-action-on-childhood-tb/</link>
		<comments>http://www.newtbdrugs.org/blog/call-to-action-on-childhood-tb/#comments</comments>
		<pubDate>Thu, 19 May 2011 19:06:14 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Action]]></category>
		<category><![CDATA[Announcements]]></category>
		<category><![CDATA[TB Pediatrics]]></category>
		<category><![CDATA[Video]]></category>
		<category><![CDATA[Voices from the Fight to Stop Tuberculosis]]></category>
		<category><![CDATA[advocacy]]></category>
		<category><![CDATA[children]]></category>
		<category><![CDATA[community]]></category>
		<category><![CDATA[crisis]]></category>
		<category><![CDATA[publications]]></category>
		<category><![CDATA[stop tb]]></category>
		<category><![CDATA[voices]]></category>

		<guid isPermaLink="false">http://blog.newtbdrugs.org/?p=2656</guid>
		<description><![CDATA[The Stop TB Partnership has issued a Call to Action on Childhood TB.  The call was an outcome of an international meeting organized jointly by the European Centre for Disease Prevention and Control (ECDC) and the Stop TB Partnership's Childhood TB Subgroup in March.  There was strong consensus among participants on the urgent need to make the voice of children heard through concerted advocacy efforts.  Links are provided to information on the Call to Action and to a page where you can sign the Call to Action on Childhood TB.  There are also links to previous coverage by the WGND on topics related to Childhood TB.  ]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/call-to-action-on-childhood-tb/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Interview with Dr. Mark Cotton &#8211; Part Two</title>
		<link>http://www.newtbdrugs.org/blog/interview-with-dr-mark-cotton-part-two/</link>
		<comments>http://www.newtbdrugs.org/blog/interview-with-dr-mark-cotton-part-two/#comments</comments>
		<pubDate>Thu, 12 May 2011 11:00:46 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[TB Pediatrics]]></category>
		<category><![CDATA[TB Treatment]]></category>
		<category><![CDATA[Video]]></category>
		<category><![CDATA[Voices from the Fight to Stop Tuberculosis]]></category>
		<category><![CDATA[pediatric]]></category>
		<category><![CDATA[South Africa]]></category>
		<category><![CDATA[tb/hiv]]></category>
		<category><![CDATA[treatment]]></category>
		<category><![CDATA[voices]]></category>

		<guid isPermaLink="false">http://blog.newtbdrugs.org/?p=2566</guid>
		<description><![CDATA[Dr. Mark Cotton is Director of Children's Infectious Diseases Clinical  Research Unit (KID-CRU) at University of Stellenbosch in Cape Town,  South Africa. Pediatric TB has emerged as a broad priority only in more recent years, though the University of Stellenbosch / Tygerberg Hospital team has been focusing on it for more than 20 years.  This is part two of our interview with him.]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/interview-with-dr-mark-cotton-part-two/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Private TB Drug Market is Larger than Expected</title>
		<link>http://www.newtbdrugs.org/blog/private-tb-drug-market-is-larger-than-expected/</link>
		<comments>http://www.newtbdrugs.org/blog/private-tb-drug-market-is-larger-than-expected/#comments</comments>
		<pubDate>Wed, 04 May 2011 21:30:49 +0000</pubDate>
		<dc:creator>TB Alliance</dc:creator>
				<category><![CDATA[Announcements]]></category>
		<category><![CDATA[market access]]></category>
		<category><![CDATA[TB News]]></category>
		<category><![CDATA[TB Prevention and Control Strategies]]></category>
		<category><![CDATA[TB Treatment]]></category>
		<category><![CDATA[Video]]></category>
		<category><![CDATA[community]]></category>
		<category><![CDATA[india]]></category>
		<category><![CDATA[markets]]></category>
		<category><![CDATA[mdr]]></category>
		<category><![CDATA[publications]]></category>
		<category><![CDATA[tb alliance]]></category>
		<category><![CDATA[treatment]]></category>

		<guid isPermaLink="false">http://blog.newtbdrugs.org/?p=2603</guid>
		<description><![CDATA[The first detailed study of the private tuberculosis (TB) drug market, published on May 4th, in the PLoS ONE journal, finds that the market is surprisingly large, and has irregular practices that could be driving treatment failures and contributing to the emergence of multidrug-resistant TB (MDR-TB).]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/private-tb-drug-market-is-larger-than-expected/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Interview with Dr. Mark Cotton &#8211; Part One</title>
		<link>http://www.newtbdrugs.org/blog/interview-with-dr-mark-cotton-part-one/</link>
		<comments>http://www.newtbdrugs.org/blog/interview-with-dr-mark-cotton-part-one/#comments</comments>
		<pubDate>Thu, 28 Apr 2011 11:00:03 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[TB Pediatrics]]></category>
		<category><![CDATA[TB Treatment]]></category>
		<category><![CDATA[Video]]></category>
		<category><![CDATA[Voices from the Fight to Stop Tuberculosis]]></category>
		<category><![CDATA[pediatric]]></category>
		<category><![CDATA[South Africa]]></category>
		<category><![CDATA[tb/hiv]]></category>
		<category><![CDATA[treatment]]></category>
		<category><![CDATA[voices]]></category>

		<guid isPermaLink="false">http://blog.newtbdrugs.org/?p=2559</guid>
		<description><![CDATA[Dr. Mark Cotton is Director of Children's Infectious Diseases Clinical Research Unit (KID-CRU) at University of Stellenbosch in Cape Town, South Africa. Pediatric TB has emerged as a broad priority only in more recent years, though the University of Stellenbosch / Tygerberg Hospital team has been focusing on it for more than 20 years. ]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/interview-with-dr-mark-cotton-part-one/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

